Pharmaceutical Business review

Cardiovascular and Garden to sign manufacturing agreement

The company will negotiate for the manufacture, testing and packaging of a revised line of health promotion supplements with a tie-in to some of the company’s other interests.

Larry Hooper, CEO of Cardiovascular Sciences, said: “We are pleased to have chosen Garden State for the production of our private label line of health promotion and protection products. Garden State is fully GMP compliant and has been awarded the National Nutritional Foods Association coveted GMP A rating.”